The global cancer vaccines market is anticipated to grow at a significant CAGR of 14.8% during the forecast period (2022-2028). Cancer vaccines, also known as therapeutic vaccinations, are a type of immunotherapy that inhibits tumor development, kills cancer cells, and prevents cancer recurrence. According to the WHO, 13.3 million new cancer cases were registered globally in 2020, up from roughly 18 million cancer cases in 2018. 9.9 million mortalities were reported in 2020. With this expanding burden, cancer prevention is one of the major concerns globally. Cancer vaccines, which are considered biological response modifiers, play an important part in the immune system’s maintenance. The rising number of cancer cases, increased investments and government financing in the creation of cancer vaccines, and technological advancements in cancer vaccines are all factors driving the growth of the market.
A full report Cancer Vaccines Market of is available at: https://orionmarketreports.com/cancer-vaccines-market/102822/
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Technology
- By Indication
- By End-User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
· Competitive Landscape- OSE Immunotherapeutics, GlaxoSmithKline Plc, F Hoffmann-La Roche AG (Genentech), Moderna Inc., and Merck & Co. Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Cancer Vaccines Market Report by Segment
By Technology
- Dendritic Cells (DC) Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen/Adjuvant Cancer Vaccines
- Viral Vector & DNA Cancer Vaccines
By Indication
- Cervical Cancer
- Prostate Cancer
- Others
By End-User
- Pediatrics
- Adults
Geographic coverage
- North America market size and/or volume
- Latin America market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Recent Developments
- Market Overview and growth analysis
- Import and Export Overview
- Volume Analysis
- Current Market Trends and Future Outlook
- Market Opportunistic and Attractive Investment Segment
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
